Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
second shot was years after the other one; was very pain full; Swollen; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of pain in extremity. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: was very pain full), swelling (Verbatim: Swollen) and drug dose administration interval too long (Verbatim: second shot was years after the other one). The outcome of the pain and swelling were resolved (duration 4 days) and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the pain and swelling to be related to Shingles vaccine. It was unknown if the company considered the pain and swelling to be related to Shingles vaccine. Linked case(s) involving the same patient: US2026AMR011150 Additional Information: GSK Receipt Date: 20-JAN-2026 This case was reported by a patient via interactive digital media. This was 1 of the 2 linked cases, reported by the same reporter. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR011150:case for 1st dose